Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | LOC100126583///IGHV4-31///IGHV@///IGHM///IGHG3///IGHG2///IGHG1///IGHD///IGHA2///IGHA1///IGH@ |
| Upstream (Parents) |
|---|
| (<<) TRBC1 → LOC100126583///IGHV4-31///IGHV@///IGHM///IGHG3///IGHG2///IGHG1///IGHD///IGHA2///IGHA1///IGH@ |
| (<<) IGKV4-1 → LOC100126583///IGHV4-31///IGHV@///IGHM///IGHG3///IGHG2///IGHG1///IGHD///IGHA2///IGHA1///IGH@ |
| (<<) IGJ → LOC100126583///IGHV4-31///IGHV@///IGHM///IGHG3///IGHG2///IGHG1///IGHD///IGHA2///IGHA1///IGH@ |
| (<<) IGKC → LOC100126583///IGHV4-31///IGHV@///IGHM///IGHG3///IGHG2///IGHG1///IGHD///IGHA2///IGHA1///IGH@ |
| Downstream (Children) |
|---|
| LOC100126583///IGHV4-31///IGHV@///IGHM///IGHG3///IGHG2///IGHG1///IGHD///IGHA2///IGHA1///IGH@ → VIP (>>) |
| LOC100126583///IGHV4-31///IGHV@///IGHM///IGHG3///IGHG2///IGHG1///IGHD///IGHA2///IGHA1///IGH@ → IGHV4-31///IGHV@///IGHM///IGHG3///IGHG1///IGHA2///IGHA1///IGH@ (>>) |
| LOC100126583///IGHV4-31///IGHV@///IGHM///IGHG3///IGHG2///IGHG1///IGHD///IGHA2///IGHA1///IGH@ → IGLV2-18///IGLV3-19///IGL@ (>>) |
| LOC100126583///IGHV4-31///IGHV@///IGHM///IGHG3///IGHG2///IGHG1///IGHD///IGHA2///IGHA1///IGH@ → PCDHGA10 (>>) |
| LOC100126583///IGHV4-31///IGHV@///IGHM///IGHG3///IGHG2///IGHG1///IGHD///IGHA2///IGHA1///IGH@ → LOC100134331///LOC100126583///LOC652128///IGHG1///IGHD///IGH@ (>>) |
